- ►ahajournals.org AV Chobanian, GL Bakris, HR Black, WC … - Hypertension, 2003 - Am Heart Assoc The National High Blood Pressure Education Program presents the complete Seventh
Report of the Joint National Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure. Like its predecessors, the purpose is to ... Cited by 8201 - Related articles - BL Direct - All 128 versions
B Williams, NR Poulter, MJ Brown, M Davis, … - Journal of Human Hypertension, 2004 - femeba.org.ar Summary of recommendations Provide advice on life-style modifications for all
people with high blood pressure (BP) and those with borderline or high-normal
BP. Advice on effective nonpharmacological interventions is provided (A). ... Cited by 458 - Related articles - BL Direct - All 34 versions
AM El Nahas, AK Bello - The Lancet, 2005 - Elsevier The worldwide rise in the number of patients with chronic kidney disease (CKD)
and consequent end-stage renal failure necessitating renal replacement therapy
is threatening to reach epidemic proportions over the next decade, and only ... Cited by 224 - Related articles - All 6 versions
G Wolf, E Ritz - Kidney international, 2005 - nature.com Received 4 November 2003; Revised 23 December 2003; Re-revised 20 February 2004;
Re-revised 28 April 2004; Accepted 1 October 2004. ... Combination therapy with
ACE inhibitors and angiotensin II receptor blockers to halt progression of ... Cited by 156 - Related articles - All 3 versions
- ►annals.org [PDF] MJ Sarnak, T Greene, X Wang, G Beck, JW … - Annals of internal medicine, 2005 - Am Coll Physicians Background: Hypertension is a risk factor for progression of chronic kidney
disease. The optimal blood pressure to slow pro- gression is unknown. Objective:
To evaluate the effects of a low target blood pressure on kidney failure ... Cited by 135 - Related articles - All 11 versions
- ►hypertension.org.za [PDF] JFE Mann, RE Schmieder, M McQueen, L Dyal, … - The Lancet, 2008 - Elsevier 784 patients permanently discontinued randomised therapy during the trial
because of hypotensive symptoms (406 on combination therapy, 149 on ramipril,
and 229 on telmisartan). The number of events for the composite primary ... Cited by 137 - Related articles - All 62 versions
- ►ahajournals.org HL Hillege, D Nitsch, MA Pfeffer, K Swedberg … - Circulation, 2006 - Am Heart Assoc From the University Medical Center Groningen, University of Groningen, the
Netherlands (HLH, DJVV); Medical Statistics Unit, London School of Hygiene and
Tropical Medicine, London, UK (DN, SP); The Cardiovascular Division, ... Cited by 129 - Related articles - All 8 versions
P Ruggenenti, A Perna, G Loriga, M Ganeva, B … - The Lancet, 2005 - Elsevier We undertook a multicentre, randomised controlled trial of patients with
non-diabetic proteinuric nephropathies receiving background treatment with the
ACE inhibitor ramipril (2·5–5 mg/day). We randomly assigned participants ... Cited by 100 - Related articles - All 8 versions
GL Bakris, MR Weir, M Secic, B Campbell, A … - Kidney international, 2004 - nature.com A systematic review was conducted to assess the differential effects of DCAs and
NDCAs on proteinuria in hypertensive adults with proteinuria, with or without
diabetes, and to determine whether these differential effects translate ... Cited by 95 - Related articles - BL Direct - All 7 versions
- ►nih.gov SI Hallan, K Dahl, CM Oien, DC Grootendorst … - British Medical Journal, 2006 - bmj.com You are seeing this message because your web browser does not support basic web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Objective To find an ... Cited by 97 - Related articles - BL Direct - All 8 versions
